IL86789A - Cyclic peptolides with cyclosporin structure with amide linkage replaced by ester linkage, their preparation and pharmaceutical compositions containing them - Google Patents

Cyclic peptolides with cyclosporin structure with amide linkage replaced by ester linkage, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL86789A
IL86789A IL86789A IL8678988A IL86789A IL 86789 A IL86789 A IL 86789A IL 86789 A IL86789 A IL 86789A IL 8678988 A IL8678988 A IL 8678988A IL 86789 A IL86789 A IL 86789A
Authority
IL
Israel
Prior art keywords
linkage
preparation
replaced
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL86789A
Other languages
English (en)
Other versions
IL86789A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL86789A0 publication Critical patent/IL86789A0/xx
Publication of IL86789A publication Critical patent/IL86789A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL86789A 1987-06-19 1988-06-17 Cyclic peptolides with cyclosporin structure with amide linkage replaced by ester linkage, their preparation and pharmaceutical compositions containing them IL86789A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH231787 1987-06-19
CH251787 1987-07-02

Publications (2)

Publication Number Publication Date
IL86789A0 IL86789A0 (en) 1988-11-30
IL86789A true IL86789A (en) 1993-02-21

Family

ID=25690129

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86789A IL86789A (en) 1987-06-19 1988-06-17 Cyclic peptolides with cyclosporin structure with amide linkage replaced by ester linkage, their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US5116816A (de)
EP (1) EP0296123B1 (de)
JP (1) JP2641256B2 (de)
KR (1) KR970010928B1 (de)
AT (1) ATE110784T1 (de)
AU (1) AU623078B2 (de)
CA (1) CA1338183C (de)
DE (1) DE3851268T2 (de)
ES (1) ES2056954T3 (de)
FI (1) FI87928C (de)
HU (1) HU204101B (de)
IE (1) IE64008B1 (de)
IL (1) IL86789A (de)
MY (1) MY103735A (de)
NZ (1) NZ225071A (de)
PH (1) PH25933A (de)
PT (1) PT87763B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU213553B (en) * 1992-05-25 1997-07-28 Biogal Gyogyszergyar Process for isolating of cyclosporin-a
JP3480848B2 (ja) * 1992-06-19 2003-12-22 タカラバイオ株式会社 環状ペプチドの合成方法
US5260215A (en) * 1992-07-20 1993-11-09 Merck & Co., Inc. Fungal microorganism ATCC 74167 capable of producing cholesterol lowering compounds
US6187547B1 (en) 1993-09-08 2001-02-13 Novartis Ag Assay kit
AU702332B2 (en) * 1994-07-27 1999-02-18 Novartis Ag Organic compounds
JP3089350B2 (ja) * 1995-11-20 2000-09-18 ギルフォード ファーマシューティカルズ インコーポレイテッド シクロフィリンロタマーゼ活性の阻害剤
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US5709797A (en) * 1996-06-05 1998-01-20 Poli Industria Chimica S.P.A. Method of isolating cyclosporins
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
AU750245B2 (en) 1997-10-08 2002-07-11 Aurinia Phamaceuticals Inc. Deuterated cyclosporine analogs and their use as immunomodulating agents
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
AU7353300A (en) 1999-09-08 2001-04-10 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
MXPA03006666A (es) 2001-01-25 2004-05-31 Guilford Pharm Inc Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US20040147433A1 (en) * 2001-06-14 2004-07-29 Marcus Keep Neuroimmunophilins for selective neuronal radioprotection
WO2003033526A2 (en) 2001-10-19 2003-04-24 Isotechnika Inc. Synthesis of cyclosporin analogs
EP2116228A1 (de) * 2001-10-19 2009-11-11 Isotechnika Inc. Neuartige Cyclosporinanalog-Mikroemulsionspräkonzentrate
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
JP2008514701A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
EP1804823A4 (de) * 2004-09-29 2010-06-09 Amr Technology Inc Neue cyclosporin-analoga und ihre pharmazeutischen anwendungen
US7361636B2 (en) * 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7696167B2 (en) * 2004-11-22 2010-04-13 Astellas Pharma Inc. Cyclic peptide compound
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法
US8501683B2 (en) * 2008-11-06 2013-08-06 Debio Recherche Pharmaceutique S.A. Cycloundecadepsipeptide compounds and use of said compounds as a medicament
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
WO2011141891A1 (en) 2010-05-12 2011-11-17 Debio Recherche Pharmaceutique S.A. Use of cycloundecadepsipeptide compounds
JP6144627B2 (ja) 2010-12-15 2017-06-07 コントラヴィア ファーマシューティカルズ、インク． アミノ酸１および３で修飾されたシクロスポリン類似体分子
EP2705856A1 (de) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Verbindungen zur Behandlung von neurodegenerativen Erkrankungen
GB201217560D0 (en) * 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
HUP1500502A2 (en) 2015-10-26 2017-04-28 Rotachrom Tech Kft Process for the purification of cyclosporin-a

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
JPS5665853A (en) * 1979-11-01 1981-06-03 Sankyo Co Ltd Mycoplanesin derivative and its preparation
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
DE3781878T2 (de) * 1986-12-15 1993-03-11 Lilly Co Eli Antibiotikum-a10255-komplex und faktoren, verfahren, mikroorganismen fuer seine herstellung.
GB8727807D0 (en) * 1987-11-27 1987-12-31 Lepetit Spa Novel antibiotic compounds named a/16686 factors a'1,a'2 and a'3

Also Published As

Publication number Publication date
HUT50220A (en) 1989-12-28
JP2641256B2 (ja) 1997-08-13
FI882926L (fi) 1988-12-20
KR890000518A (ko) 1989-03-15
IE64008B1 (en) 1995-06-28
EP0296123A3 (en) 1990-06-20
FI87928C (fi) 1993-03-10
FI87928B (fi) 1992-11-30
NZ225071A (en) 1991-05-28
AU623078B2 (en) 1992-05-07
PT87763B (pt) 1992-10-30
DE3851268D1 (de) 1994-10-06
JPS6425798A (en) 1989-01-27
PT87763A (pt) 1988-07-01
AU1812488A (en) 1988-12-22
ES2056954T3 (es) 1994-10-16
FI882926A0 (fi) 1988-06-17
EP0296123A2 (de) 1988-12-21
PH25933A (en) 1991-12-19
DE3851268T2 (de) 1995-01-26
EP0296123B1 (de) 1994-08-31
CA1338183C (en) 1996-03-26
US5116816A (en) 1992-05-26
HU204101B (en) 1991-11-28
MY103735A (en) 1993-09-30
ATE110784T1 (de) 1994-09-15
KR970010928B1 (ko) 1997-07-02
IE881838L (en) 1988-12-19
IL86789A0 (en) 1988-11-30

Similar Documents

Publication Publication Date Title
IL86789A0 (en) Cyclic peptolides,their preparation and pharmaceutical compositions containing them
CA2194533A1 (en) Light-curing composite material
AU588860B2 (en) Improvements in or relating to organic compounds
ES2058796T3 (es) Aislamiento y elucidacion estructural del depsipeptido citostatico lineal dolastatina 15.
ES2020738A6 (es) Composiciones farmaceuticas comprendiendo ciclosporinas.
EP1449921A3 (de) Neuartige, biologisch aktive Polypeptide, ihre Herstellung und diese Polypeptide enthaltende pharmazeutische Zusammensetzung
IE780932L (en) Cyclosporins (cyclic polypeptides)
CA2123321A1 (en) Combination chemotherapy
CA2154170A1 (en) Cyclic imide thione activated polyalkylene oxides
IE883779L (en) Cyclosporin crystal form
DK0482013T3 (da) Ikke-glycolyserede humant interleukin-3 analoge proteiner
GB1491509A (en) Metabolites s7481/f-1 and 1f-2
CA2087164A1 (en) Target specific antibody-superantigen conjugates and their preparation
CA2006087A1 (en) Polypeptides isolated from the venom of the spider hololena curta
CA2010739A1 (en) Bipolar voltage to frequency converter
AU556908B2 (en) Hexahydronaphth(1,2-beta)-1,4-oxazines
CA2012867A1 (en) Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
AU4165289A (en) Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
NZ334073A (en) Process for producing cyclodepsipeptide compounds
DE69712055D1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
GB1478469A (en) Ansamycin antibiotics produced by a species of micromonospora
FR2405297A1 (fr) Nouveaux antibiotiques et leur preparation
HUT50360A (en) Process for producing antibiotic uk-61689 by microbiological way and pharmaceutical composition comprising the active ingredient and mycelium
GR3006965T3 (de)
EP0225648A3 (de) Zubereitungen mit hochpotentierter antigenischer Wirkung

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired